INTRODUCTION {#sec1-1}
============

Drug resistance poses a therapeutic problem not only in the hospital settings, but also in the community as most of the bacteria have acquired resistance to multiple antibiotics.\[[@ref1][@ref2]\] The various mechanisms of drug resistance in Gram-negative bacteria include extended spectrum beta-lactamases (ESBL) production, *Amp*C β-lactamase production, efflux mechanism and porin deficiency. In the clinical laboratory settings, the commonly detected enzymes causing resistance are *Amp*C β-lactamases and ESBLs. Clinical relevance of *Amp*C β-lactamases lies in the fact that they confer resistance to both narrow and broad spectrum cephalosporins, beta-lactam/beta-lactamase inhibitor combinations and aztreonam.\[[@ref3]\]

*Amp*C β-lactamases can be chromosomally or plasmid mediated. The plasmid mediated *Amp*C β-lactamases hydrolyze all β-lactam antibiotics except cefepime and carbapenems. The plasmid-mediated *Amp*C genes are derived from inducible chromosomal genes that have been mobilized among various organisms. The commonly reported genotypes are ACC, FOX, MOX, DHA, CMY, CIT and EBC.\[[@ref4][@ref5][@ref6]\] These mobilized plasmid mediated enzymes confer a resistance pattern similar to the overproduction of chromosomal *Amp*C β-lactamases, which also involve all β-lactam antibiotics except for carbapenems and cefepime.\[[@ref7]\]

Detection of *Amp*C is important to improve the clinical management of patients suffering from infections and would also provide us with sound epidemiological data. However, there are no Clinical and Laboratory Standards Institute guidelines for detection of *Amp*C mediated resistance in Gram-negative clinical isolates and hence, it usually poses a problem due to misleading results, especially so in phenotypic tests.\[[@ref8]\]

Personnel qualifications {#sec2-1}
------------------------

The test performer should be having a diploma in laboratory technologies and preferably university graduate in biological sciences with sufficient experience.

Education and training {#sec2-2}
----------------------

Personnel are required to be knowledgeable of the procedures in the microbiology laboratory. The laboratory staff should confirm that they can properly perform the procedures before commencing work. The details are given in [Table 1](#T1){ref-type="table"}.

###### 

Education and training must be given on the following topics

![](JLP-6-1-g001)

PROCEDURE {#sec1-2}
=========

Techniques to identify *Amp*C β-lactamase-producing isolates are available but are still evolving and are not yet optimized for the clinical laboratory, which leads to the underestimation of these resistance mechanisms. Carbapenems can usually be used to treat infections due to *Amp*C-producing bacteria, but carbapenem resistance can arise in some organisms by mutations that reduce influx (outer membrane porin loss) or enhance efflux (efflux pump activation).

REQUIREMENTS {#sec1-3}
============

The list of all the requirements are given in [Table 2](#T2){ref-type="table"}.

###### 

List of all the requirements for performing the test
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Isolates {#sec2-3}
--------

Gram-negative bacterial isolates recovered from clinical samples.

Preparation of reagents and chemicals {#sec2-4}
-------------------------------------

300 μg phenylboronic acidWeigh 150 mg phenylboronic acid and dissolve in 10 ml sterile distilled waterUse it as 15 μg/μl stockStore at 4°C0.5 M ethylenediaminetetraacetic acid (EDTA) bufferWeigh 18.6 g EDTA and add distilled water to 90 mlAdjust pH to 8.0Add distilled water and make final volume 100 mlStore at 4°CTris-EDTA (TE) buffer50X TE (stock solution)Weigh 121 g Tris base and dissolve in 400 ml distilled waterAdd 50 ml 0.5 M EDTAAdd distilled water and make final volume 500 mlStore at 4°CTE buffer (working)Dilute 50X master stock to 1X with distilled water.Primer reconstitution.

Primers are often shipped and received in a lyophilized state. First create a master 100X stock (for each primer and then dilute it to a 20X working stock).

Master stock, 100 μM

100 μM = X nmoles lyophilized primer + (X × 10 μl molecular grade H~2~O)To determine the amount of H~2~O to add to the lyophilized primer simply multiply the number of nmol of primer in the tube by 10 and that will be the amount of H~2~O to add to make a 100 μM primer stockVortex tube and incubate at room temperature for 10 min.

Working stock, 20 μM

Dilute the primer master stock in a sterile microcentrifuge tube 1:5 with molecular grade H~2~O.

TEST PROCEDURE {#sec1-4}
==============

What is unnecessary? {#sec2-5}
--------------------

It is unnecessary to detect *Amp*C production in organisms that produce an inducible chromosomal *Amp*C β-lactamase because the organism identification is indicative of *Amp*C production; i.e. 100% isolates of *Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, Serratia marcescens, Providencia* sp., *Morganella morganii, Hafnia alvei, Aeromonas* sp., and *P. aeruginosa* can be assumed to be *Amp*C producers. Detection of an *Amp*C β-lactamase in *Klebsiella* sp., *Citrobacter koseri* or *Proteus mirabilis* is confirmatory for plasmid-mediated *Amp*C production because these organisms lack a chromosomal *Amp*C β-lactamases.\[[@ref9][@ref10]\]

Screening {#sec2-6}
---------

RequirementTest organismNormal salineBlood agar platesMueller-Hinton agar (MHA) plates30-μg cefoxitin diskProcedureMake 0.5 McFarland bacterial suspension in normal saline prepared from an overnight blood agar plateInoculate surface of MHA plate with this suspension by swabbingPlace 30-μg cefoxitin disk on inoculated MHAInvert the plate and incubate overnight at 35°CPlate reading and interpretationAfter overnight incubation measure zone diameter around 30-μg cefoxitin diskSelect the isolates with zone diameters less than 18 mm for confirmation of *Amp*C production.

Phenotypic confirmatory tests {#sec2-7}
-----------------------------

### Three-dimensional extract test {#sec3-1}

RequirementTest organism*Escherichia coli* ATCC 25922 or *E. coli* ATCC 11775Normal salineBlood agar platesMHA plates12 ml brain heart infusion (BHI) broth30-μg cefoxitin diskSterile bladeProcedurePrepare 0.5 McFarland bacterial suspension from an overnight blood agar plateInoculate 12 ml BHI broth with 50 μl of 0.5 McFarland bacterial suspension and incubate for 4 h at 37°CConcentrate cells by centrifugation and freeze-thaw 5 times to prepare crude enzymePrepare 0.5 McFarland bacterial suspension using one of two *E. coli* ATCC 25922 or ATCC 11775 and inoculate surface of MHA plate by using this suspensionPlace 30-μg cefoxitin disk on the inoculated agar plateWith a sterile scalpel blade, cut a slit beginning 5 mm from the edge of the disk in an outward radial directionBy using a pipette, dispense 25-30 μl of enzyme preparation into the slit, beginning near the disk and moving outward, avoiding slit overfillIncubate inoculated media overnight at 37°CPlate reading and interpretationAfter overnight incubation check the enhanced growth of the surface organism at the point where the slit intersectedIf there is a zone of inhibition of surface organism, the test is positive three-dimensional test \[[Figure 1](#F1){ref-type="fig"}\].

![Representation of three dimensional extract test. (a) Zone of inhibition showing positive test, (b) no zone of inhibition showing negative test. \*30 μg cefoxitin disk](JLP-6-1-g003){#F1}

### *Amp*C disk test {#sec3-2}

Requirements*Amp*C disks (filter paper disks containing TE)30 μg cefoxitin diskBlood agar platesMHA platesTest organisms*E. coli* ATCC 25922Normal salineProcedurePrepare 0.5 McFarland bacterial suspension of *E. coli* ATCC 25922Inoculate surface of MHA plate using this suspension as per standard disk diffusion methodImmediately prior to use, rehydrate *Amp*C disk with 20 μl of saline and several colonies of each test organism apply to a diskPlace a 30 μg cefoxitin disk on the inoculated surface of the MHAPlace inoculated *Amp*C disk almost touching the antibiotic disk with the inoculated disk face in contact with the agar surfaceInvert the plate and incubate overnight at 35°C in ambient airPlate reading and interpretationAfter overnight incubation, examine the plate for either an indentation or a flattening of the zone of inhibitionIf there is any zone of inhibition, it indicates enzymatic inactivation of cefoxitin (positive result)If no zone inhibition, indicates no significant inactivation of cefoxitin (negative result) \[[Figure 2](#F2){ref-type="fig"}\].

![Representation of *Amp*C disk test. (a) Zone of inhibition showing positive test results, (b) no zone of inhibition showing negative test results, \*AmpC disks (filter paper containing tris-EDTA), CX: 30μg cefoxifin disks](JLP-6-1-g004){#F2}

### Boronic acid disk test method {#sec3-3}

RequirementsTest organism30 μg cefoxitin diskPhenylboronic acidMHA plates.ProcedurePrepare 0.5 McFarland bacterial suspension from an overnight blood agar plateInoculate surface of MHA plate using this suspension as per standard disk diffusion methodPlace a 30 μg cefoxitin disk on the inoculated surface of the MHAUsing sterile tips, dispense 20 μl of 15 μg/ml phenylboronic acid onto the diskLet the disk absorb itInvert the plate and incubate overnight at 35°C.Plate reading and interpretationAfter overnight incubation, compare the zone diameter around the antibiotic disk with added boronic acid and the antibiotic-containing disk aloneAn organism that demonstrates a defined increase (≥5-mm) in zone diameter around the antibiotic disk with added boronic acid consider to be an *Amp*C producer \[[Figure 3](#F3){ref-type="fig"}\].\[[@ref5]\]

![Representation of boronic acid disk test. A: 30 μg cefoxitin disk supplemented with 300μg of phenyl boronic acid. B: 30 μg cofoxitin disk alone](JLP-6-1-g005){#F3}

### Disk approximation test {#sec3-4}

RequirementsTest organismNormal saline10 μg imipenem disk30 μg cefoxitin disk20/10 μg amoxicillin-clavulanate disk30 μg ceftazidime diskMHA PlatesProcedurePrepare 0.5 McFarland bacterial suspension from an overnight blood agar plateInoculate surface of MHA plate using this suspension as per standard diskdiffusion methodPlace a 30 μg ceftazidime disk at the center on the platePlace 10 μg imipenem, 30 μg cefoxitin, and 20/10 μg amoxicillin-clavulanate disks at a distance of 20 mm from ceftazidime diskInvert the plate and incubate overnight at 35°CPlate reading and interpretationAfter overnight incubation, examine the plate for any obvious blunting or flattening of the zone of inhibition between the ceftazidime disk and the inducing substrates (imipenem, cefoxitin and amoxicillin-clavulanate disk)If there is any blunting or flattening of the zone, consider as a positive result for *Amp*C production \[[Figure 4](#F4){ref-type="fig"}\].

![Representation of disk approximation test. Flattening of zone of ceftazidime toward imipenem disk (inducing substrate) showing positive result. IMP: Imipenem (10 μg), CAZ: Ceftazidime (10 μg), AMC: Amoxillin-clavulanate (20/10 μg)](JLP-6-1-g006){#F4}

### Multiplex polymerase chain reaction for plasmid mediated *Amp*C genes {#sec3-5}

Phenotypic tests do not differentiate between chromosomal and plasmid mediated *Amp*C β-lactamases. Plasmid-mediated *Amp*C β-lactamases are most accurately detected with the multiplex *Amp*C PCR test.

### Preparation of template deoxyribonucleic acid (DNA) {#sec3-6}

RequirementsTest organismMolecular biology grade waterMicrocentrifuge tubesAbsolute ethanolDNA extraction kitProcedureInoculate a single colony of each organism into 5 ml of Luria-Bertani broth and incubate for 20 h at 37°C with shakingHarvest cells from 1.5 ml of the overnight culture by centrifugation at 10,000 × *g* for 5 minDiscard supernatant, re-suspend the pellet in 500 μl of distilled waterExtract total DNA by using DNA extraction kit according to manufacturer\'s instructionsQuantify total DNA prior to the multiplex PCR using spectrophotometer

### Multiplex PCR {#sec3-7}

Requirements0.5-ml thin-walled PCR tubesMolecular biology grade waterTaq DNA polymerase (5U/μl)10X Taq buffer with KCLTris-HCl (pH 8.4)25 mM MgCl~2~DNTP~S~ 10MmProcedureMake a master mix containing 20 mM Tris-HCl (pH 8.4); 50 mM KCl; 0.2 mM each dNTPs; 1.5 mM MgCl2; 0.6 μM primers MOXMF, MOXMR, CITMF, CITMR, DHAMF, and DHAMR; 0.5 μM primers ACCMF, ACCMR, EBCMF, and EBCMR; 0.4 μM primers FOXMF and FOXMR; and 1.25 U of Taq DNA polymerase. Add 2 µl DNA template. The list of all the primers are given in [Table 3](#T3){ref-type="table"}.Set the PCR program on an initial denaturation step at 94°C for 3 min, followed by 25 cycles of DNA denaturation at 94°C for 30s, primer annealing at 64°C for 30s, and primer extension at 72°C for 1 min. After the last cycle, a final extension step at 72°C for 7 minSet the tube in the PCR machine and run the program.

###### 

Primers for amplification of *AmpC* genes
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### Electrophoresis {#sec3-8}

RequirementsAgaroseEthidium bromideLoading die100-bp DNA ladderProcedurePrepare 2% agarose gel in 1X TE bufferAnalyze 5 μl PCR product mixed with 1 μl 6X loading dieUse 100-bp DNA ladder as a markerStain gel with ethidium bromide (10 μg/ml) and analyze the presence of bands in ultraviolet transilluminatorUse the PCR mixtures with the addition of water in place of template DNA as negative control.

### Plate disposal {#sec3-9}

Keep all culture plates sealed inside blue plastic bags and seal in an autoclave bagAutoclave at 121°C for 30 minDiscard the sealed sterilized bags in the site designed for this purpose.
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